Neurovascular Devices / Interventional Neurology

Neurovascular Devices / Interventional Neurology

Global Neurovascular Devices / Interventional Neurology Market to Reach US$6.1 Billion by 2030

The global market for Neurovascular Devices / Interventional Neurology estimated at US$3.7 Billion in the year 2023, is expected to reach US$6.1 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Aneurysm Coiling & Embolization Devices, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Neurothrombectomy Devices segment is estimated at 6.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 6.9% CAGR

The Neurovascular Devices / Interventional Neurology market in the U.S. is estimated at US$1.0 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$938.6 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.9% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Neurovascular Devices/Interventional Neurology Market - Key Trends & Drivers Summarized

What Are Neurovascular Devices and Why Are They Critical in Neurology?
Neurovascular devices are medical tools designed to treat disorders affecting the blood vessels in the brain and spine. These devices are essential for procedures like treating strokes, aneurysms, arteriovenous malformations (AVMs), and other vascular abnormalities in the central nervous system. The category includes products such as embolization coils, neurovascular stents, thrombectomy devices, and catheters, which allow interventional neurologists to perform minimally invasive procedures to restore normal blood flow and reduce the risk of hemorrhage or ischemia.

The importance of neurovascular devices has grown exponentially with the rise of interventional neurology, a field that focuses on using these devices to treat cerebrovascular diseases. Stroke, one of the leading causes of death and disability worldwide, is a primary condition treated with these tools. Minimally invasive neurovascular interventions offer significant advantages, such as faster recovery times, reduced risk of complications, and higher success rates compared to traditional open-brain surgery. As the global burden of stroke and aneurysms rises, neurovascular devices play a critical role in saving lives and improving outcomes for patients.

How Is the Neurovascular Devices Market Evolving?
The neurovascular devices market is evolving rapidly due to advances in technology and the growing preference for minimally invasive procedures. One of the key trends shaping the market is the development of next-generation thrombectomy devices, which are used to remove blood clots in patients with ischemic stroke. These devices have seen continuous innovation, with improvements in their design allowing for faster and more effective clot removal, which in turn reduces the time between stroke onset and treatment, improving patient outcomes. Mechanical thrombectomy is now considered the gold standard for acute ischemic stroke, leading to a surge in demand for these devices.

Another significant trend is the increasing use of flow diverters for the treatment of complex brain aneurysms. Flow diverters are stent-like devices designed to redirect blood flow away from an aneurysm, promoting healing of the vessel and preventing rupture. These devices offer a less invasive and more effective alternative to traditional coiling procedures for large or difficult-to-reach aneurysms. Additionally, the market is witnessing growth in demand for neurovascular access products such as guidewires and microcatheters, which are critical for delivering therapeutic devices to the brain with precision.

Which Conditions Are Driving the Adoption of Neurovascular Devices?
Several conditions are driving the increased adoption of neurovascular devices, with stroke being the most significant. Strokes, particularly ischemic strokes caused by blood clots, require immediate intervention to restore blood flow and prevent permanent brain damage. Neurovascular devices, such as stent retrievers and aspiration catheters, are essential for these life-saving procedures. Hemorrhagic strokes, which result from ruptured blood vessels, also demand the use of devices like aneurysm clips, coils, and flow diverters to prevent further bleeding and stabilize the patient.

Aneurysms are another major driver, as they can lead to life-threatening bleeding if they rupture. Minimally invasive interventions using devices like embolization coils or flow diverters allow for targeted treatment of aneurysms without the need for open surgery. Arteriovenous malformations (AVMs) and dural arteriovenous fistulas (DAVFs), which are abnormal connections between arteries and veins in the brain, are also treated using neurovascular devices. These conditions often require embolization or surgical resection, both of which rely on specialized tools to reduce the risk of rupture and bleeding.

What Are the Key Growth Drivers in the Neurovascular Devices Market?
The growth in the neurovascular devices market is driven by several key factors. The increasing prevalence of stroke and brain aneurysms globally is a major driver, particularly as aging populations face a higher risk of these conditions. Another critical factor is the growing demand for minimally invasive surgical procedures, which offer patients faster recovery times, reduced hospital stays, and lower rates of complications. As interventional neurology continues to advance, the demand for cutting-edge devices such as thrombectomy systems, stents, and embolization products is rising.

Technological advancements in neurovascular devices are also fueling market growth. The development of next-generation thrombectomy devices, flow diverters, and embolization coils with enhanced precision and safety features is expanding the range of treatable conditions. In addition, the increasing investments in healthcare infrastructure, especially in emerging markets, are boosting access to neurovascular treatments. Government initiatives focused on reducing stroke-related mortality and improving outcomes are also contributing to the market’s expansion, along with rising awareness of stroke prevention and early treatment.

Select Competitors (Total 12 Featured) -

• Abbott Laboratories
• Boston Scientific Corporation
• Johnson & Johnson
• Medtronic PLC
• Merit Medical Systems, Inc.
• MicroPort Scientific Corporation
• Penumbra, Inc.
• Stryker Corporation
• Terumo Corporation
• W.L. Gore & Associates, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.